Buscar

01/05/2025 Thalamic-Basal Ganglia Connectivity Patterns as a Sex-Specific Vulnerability Factor to OCD Symptomatology in Healthy Adolescents
Miranda-Olivos, R, Porta-Casteràs, D, de la Peña-arteaga, V, Contreras-Rodríguez, O, Guxens, M, Vrijheid, M, Cardoner, N, Cano, M. Thalamic-Basal Ganglia Connectivity Patterns as a Sex-Specific Vulnerability Factor to OCD Symptomatology in Healthy Adolescents. BIOLOGICAL PSYCHIATRY. 2025; 97(9)DOI:. PMID:. IF:9.000(Q1/1D).
01/04/2025 Switching to insulin lispro U-200 in a pregnant woman using a 780G advanced hybrid closed-loop led to a rapid improvement in glucose metrics
Mendoza, LC, Cohen, O, Smaniotto, V, Corcoy, R. Switching to insulin lispro U-200 in a pregnant woman using a 780G advanced hybrid closed-loop led to a rapid improvement in glucose metrics. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 222DOI:10.1016/j.diabres.2025.112047. PMID:39961514. IF:7.400(Q1/1D).
01/03/2026 Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes
Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes. JOURNAL OF WOMENS HEALTH. 2026; 35(3)DOI:10.1177/15409996251401741. PMID:41449991. IF:1.900(Q1/2D).
14/01/2026 Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort
Torres, G, Gracia-Lavedan, E, González, J, Henríquez-Beltrán, M, Targa, ADS, Royo, M, Bermúdez-López, M, Castro-Boqué, E, Valdivielso, JM, Pamplona, R, Mauricio, D, Lecube, A, Barbé, F, De Batlle, J, Miquel, E, Ortega, M, Portero-Otín, M, Jové, M, Hernández, M, Rius, F, Franch-Nadal, J, Castelblanco, E, Godoy, P, Martinez-Alonso, M, Simó, R, Hernández, C, Fernández, E. Skin advanced glycation end-products do not predict pulmonary function trajectories in adults from the ILERVAS cohort. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-33414-8. PMID:41535697. IF:3.900(Q1/2D).
06/01/2026 Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort
León-Mengíbar, J, Malagón, MM, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro, E, Fernández, E, Caixàs, A, Hernández, M, Lopez-Cano, C, Gordon, A, Guzman-Ruiz, R, Cusi, K, Lecube, A. Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort. Frontiers in Endocrinology. 2026; 16DOI:10.3389/fendo.2025.1651689. PMID:41567808. IF:4.600(Q1/3D).
01/01/2026 In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used
Xie, XL, Liu, JM, López, A, Garcia-Patterson, A, Adelantado, JM, López, E, Corcoy, R. In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used. ACTA DIABETOLOGICA. 2026; 63(1)DOI:10.1007/s00592-025-02587-z. PMID:41055719. IF:2.900(Q3/6D).
01/01/2026 Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data
Navarro-González, JF, de Isla, LP, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Almanza, MR, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, Blanco-Carrasco, AJ, Torres, JFM. Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data. Kidney Diseases. 2026; 12(1)DOI:10.1159/000547604. PMID:41510180. IF:3.100(Q1/3D).
01/01/2026 Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study
Ritzel, R, Davies, MJ, Hao, LC, Ji, LN, Lintu, MK, Mabunay, A, Mauricio, D, Bailey, T. Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study. Diabetes Therapy. 2026; 17(1)DOI:10.1007/s13300-025-01798-5. PMID:41269514. IF:2.600(Q3/6D).